Jung Bok Lee

5.6k total citations
124 papers, 3.0k citations indexed

About

Jung Bok Lee is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Jung Bok Lee has authored 124 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 35 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Jung Bok Lee's work include Pluripotent Stem Cells Research (21 papers), CRISPR and Genetic Engineering (9 papers) and Ovarian cancer diagnosis and treatment (9 papers). Jung Bok Lee is often cited by papers focused on Pluripotent Stem Cells Research (21 papers), CRISPR and Genetic Engineering (9 papers) and Ovarian cancer diagnosis and treatment (9 papers). Jung Bok Lee collaborates with scholars based in South Korea, Canada and United States. Jung Bok Lee's co-authors include Jae Won Lee, Mickie Bhatia, Seuck Heun Song, Mira Park, Hyun Soo Yoon, Sun Jong Kim, Jong Hyuk Park, Sung Il Roh, Jong‐Hee Lee and Seok‐Ho Hong and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Jung Bok Lee

121 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jung Bok Lee South Korea	32	1.1k	575	406	402	386	124	3.0k
Hao Chen China	31	1.7k 1.4×	511 0.9×	278 0.7×	386 1.0×	418 1.1×	224	3.8k
Chris Jackson Australia	41	1.4k 1.2×	816 1.4×	400 1.0×	203 0.5×	448 1.2×	170	6.4k
Hiroyuki Kobayashi Japan	30	916 0.8×	624 1.1×	195 0.5×	406 1.0×	346 0.9×	224	3.4k
Kwon‐Ha Yoon South Korea	33	1.2k 1.0×	716 1.2×	515 1.3×	605 1.5×	631 1.6×	162	4.0k
Wenli Zhang China	31	1.1k 1.0×	569 1.0×	608 1.5×	435 1.1×	268 0.7×	232	3.7k
Wei‐Chou Lin Taiwan	33	958 0.8×	747 1.3×	478 1.2×	478 1.2×	414 1.1×	134	3.3k
Xiaofeng Chen China	33	1.6k 1.4×	249 0.4×	471 1.2×	247 0.6×	292 0.8×	231	4.0k
Marco Prunotto Switzerland	26	1.5k 1.3×	350 0.6×	174 0.4×	619 1.5×	346 0.9×	80	3.8k
Lijuan Wang China	29	649 0.6×	529 0.9×	243 0.6×	317 0.8×	745 1.9×	173	3.3k
Hyun‐Ah Kim South Korea	32	1.5k 1.3×	617 1.1×	270 0.7×	362 0.9×	868 2.2×	228	4.1k

Countries citing papers authored by Jung Bok Lee

Since Specialization

Citations

This map shows the geographic impact of Jung Bok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Bok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Bok Lee more than expected).

Fields of papers citing papers by Jung Bok Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Bok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Bok Lee. The network helps show where Jung Bok Lee may publish in the future.

Co-authorship network of co-authors of Jung Bok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Bok Lee. A scholar is included among the top collaborators of Jung Bok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Bok Lee. Jung Bok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Se Ik, Je‐Gun Joung, Yoo‐Na Kim, et al.. (2024). Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. Gynecologic Oncology. 182. 7–14. 4 indexed citations

Lee, Jung‐Yun, David S.P. Tan, Isabelle Ray‐Coquard, et al.. (2024). Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80). Journal of Gynecologic Oncology. 36(1). e51–e51. 5 indexed citations

Tan, David S.P., Jung Bok Lee, Els Van Nieuwenhuysen, et al.. (2024). A three-arm randomized phase II study of dostarlimab alone or with bevacizumab versus nonplatinum chemotherapy in recurrent gynecological clear cell carcinoma: DOVE (APGOT-OV7/ENGOT-ov80 study).. Journal of Clinical Oncology. 42(16_suppl). TPS5627–TPS5627. 4 indexed citations

Choi, Byungjin, Jennifer S. McDonald, Sang Hyun Choi, et al.. (2024). Risk of Contrast-Induced Acute Kidney Injury in Computed Tomography. Investigative Radiology. 60(6). 376–386. 1 indexed citations

Lee, Woohyung, Minyoung Oh, Jae Seung Kim, et al.. (2024). Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer. International Journal of Surgery. 110(7). 4074–4082. 6 indexed citations

Yook, Jeong Hwan, Moon‐Won Yoo, Beom Su Kim, et al.. (2024). Impact of Routine Follow-Ups After Curative Gastrectomy in Elderly Patients with Early Gastric Cancer. Annals of Surgical Oncology. 32(4). 2629–2636.

Kim, Yoo‐Na, Je‐Gun Joung, Eunhyang Park, et al.. (2023). Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045. International Journal of Cancer. 153(12). 2032–2044. 6 indexed citations

Park, Junsik, Jung Bok Lee, Jung Bok Lee, et al.. (2023). Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D. Journal for ImmunoTherapy of Cancer. 11(10). e007444–e007444. 11 indexed citations

Lee, Seung Soo, Kyung Hae Jung, Jung Bok Lee, et al.. (2022). Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning–measured Spleen Volume at CT. Radiology. 305(3). 606–613. 6 indexed citations

10.

Yoon, Yong‐Hoon, Jung‐Min Ahn, Jung Bok Lee, et al.. (2022). Time‐Dependent Impact of Sex on the Long‐Term Outcomes After Left Main Revascularization. Journal of the American Heart Association. 11(5). e021720–e021720. 3 indexed citations

11.

Kim, Dong Wook, Kyung Won Kim, Yousun Ko, et al.. (2021). Effects of Contrast Phases on Automated Measurements of Muscle Quantity and Quality Using CT. Korean Journal of Radiology. 22(11). 1909–1909. 6 indexed citations

12.

Kang, Jieun, Jae Seung Lee, Sei Won Lee, Jung Bok Lee, & Yeon‐Mok Oh. (2021). Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials. Respiratory Research. 22(1). 55–55. 1 indexed citations

13.

Kwon, Hyunwook, Young Hoon Kim, Tae‐Won Kwon, et al.. (2019). Effect of arteriovenous access closure and timing on kidney function in kidney transplant recipients. PLoS ONE. 14(12). e0226309–e0226309. 2 indexed citations

14.

Koo, Hyun Jung, et al.. (2016). Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis. PLoS ONE. 11(9). e0161437–e0161437. 54 indexed citations

15.

Yun, Woo Jin, Sang Min Lee, Sang Hyung Lee, et al.. (2015). A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians. Journal of Cosmetic and Laser Therapy. 17(5). 259–266. 16 indexed citations

16.

Cerdan, Chantal, et al.. (2012). Activin A Promotes Hematopoietic Fated Mesoderm Development Through Upregulation of Brachyury in Human Embryonic Stem Cells. Stem Cells and Development. 21(15). 2866–2877. 20 indexed citations

17.

Schnerch, Angelique, Jung Bok Lee, Monica Graham, Borhane Guezguez, & Mickie Bhatia. (2012). Human Embryonic Stem Cell-Derived Hematopoietic Cells Maintain Core Epigenetic Machinery of the Polycomb Group/Trithorax Group Complexes Distinctly from Functional Adult Hematopoietic Stem Cells. Stem Cells and Development. 22(1). 73–89. 12 indexed citations

18.

Lee, Jae Won, Jae Won Lee, Jung Bok Lee, et al.. (2004). An extensive comparison of recent classification tools applied to microarray data. Computational Statistics & Data Analysis. 48(4). 869–885. 292 indexed citations

19.

Choi, Whan-Seok, Sang Hoon Jung, Kyung Su Park, et al.. (2003). The Prevelance of Diagnosis as Raynaud's Disease among the People Complaint of Abnormal Sensation on Hands and Feet. Gajeong yihag hoeji. 24(12). 1085–1091. 5 indexed citations

20.

Hong, Seok Ho, Young Jin Lee, Ji‐Won Lee, et al.. (1996). Epidemiologia del virus respiratorio sincicial en los hemisferios norte y sur. Molecules and Cells. 16(3). 166–168. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact